I think we need a better explanation than this.
Two minutes using Google, and you could fully understand the situation. Instead, you want to spin all kinds of hypotheticals and conspiracy theories.
The Operation Warp Speed agreement with Pfizer was for $1.95 billion. It was an advance-purchase agreement for 100 million doses of the vaccine. Pfizer does not get a penny from the US government until 100 million doses are delivered in the USA. It's actually a pretty simple, and rather standard, contract, and there isn't anything fungible about it.
I didn't say anything about hypotheticals or conspiracy theories. Pfizer said they would deliver 20 million doses and now they're cutting that number in half. They say it's due to supply chain issues but didn't offer specifics. I said we need a better explanation. What's hypothetical and where's the conspiracy?
I also said that money is fungible and the $1.95 billion would pay for a lot of different things. I think it's safe to say that some will cover development, some will cover production costs, and some will be profit. I think there's no doubt they were motivated by big orders from the U.S. as well as other countries.
I did say that I thought the U.S. was guaranteeing payment even if not FDA approved and I stand corrected. But I never suggested any type of conspiracy.
Medical provider? Are you in sales? As a guy that has taken products from concept to high volume production production I can assure you that although not trivial the problems that you mentioned all have straight forward solutions.
I just googled to test my memory. A Reuters article and a Washington Post article both mentioned 20 million doses this year (and 20 million per month after that). A November 17th Boston Globe article quotes Fauci as saying we could have 25 million from Pfizer and 15 million from Moderna. I'm not saying I'm right, I'm just saying what I've read in several places.No idea where you are getting this "20 million dose number." Pfizer cut an earlier production estimate of 100 million doses in 2020 to 50 million, the latter enough to vaccinate 25 million people.
There was an earlier report that Pfizer had already produced 20 million doses.
I am willing to bet you more money that 50% number will get delayed delivery as well. i am sure these guys are going balls to the wall to do as much as they can, but only so much can be done.
I just googled to test my memory. A Reuters article and a Washington Post article both mentioned 20 million doses this year (and 20 million per month after that). A November 17th Boston Globe article quotes Fauci as saying we could have 25 million from Pfizer and 15 million from Moderna. I'm not saying I'm right, I'm just saying what I've read in several places.
Perhaps your numbers are worldwide and my numbers are U.S.
P.S. I just heard Dr Hahn on TV say that he still thinks we could get 20 million doses from Pfizer by year end.
Huh? Pfizer says 50 mil, which translates into 25mm people. I've seen nothing where Pfizer talks about delivering 10 mm doses.
I kindly suggested this to him a while back but he does not seem to understand what will take place.Cletus, you clearly have never developed any product and taken it to high volume in a short amount of time. You should just be quiet and watch it happen.
below cut and past from article from today after yesterday's announcement that they would not meet the 100 million doses previously stated a couple of months ago. notice the hedge.....UP TO.....before the 50 million doses. these companies are not stupid. I am 100% certain Pfizer is doing everything possible to maximize the doses they can produce as it both is the right thing to do for the world and just happens to make them the most money. But again, by end of year I would be in the 25-30 million doses range which is 12-15 million people. Then they all have to get distributed and people vaccinated.
Pfizer is planning to distribute up to 50 million doses of its shot, dubbed BNT162b2, by the end of the year, a significant cut from the 100 million doses the drugmaker initially intended. Back in November, those plans were revised due to a slower-than-expected manufacturing scale-up and raw material shortages, a Pfizer spokesman said.
In the link above, Dr Offit said it’s too early to tell how frequently the vaccine may need to be readministered . But the findings to date are supportive of a longer term immunity .Was talking to my cousin who was a former high level employee at Merck. She was significantly involved in a number of vaccines during her time there. She has still has a lot of contacts in the industry and has said people are telling her that SARS CoV- 2 vaccines may have to be yearly.
I hope her experts are wrong.
Yeah, I know with SARS and MERS immunity seems to be durable and these are very closely related viruses.In the link above, Dr Offit said it’s too early to tell how frequently the vaccine may need to be readministered . But the findings to date are supportive of a longer term immunity .
Give it a rest man and just watch how things go.so as i keep beating a dead horse, i really think this roll out is going to be very bad. seems like nobody knows what the F is going on. when hospital CEO's are coming out and saying they don't know anything other than they are given a new date every few days on when the vaccine is coming, including not knowing how many they will get, something is wrong. sounds like they really don't have much of a plan on how to even vaccinate people considering they don't know the side effects and good point in not being able to vaccinate the whole hospital in a day and then have 33% of the staff call out sick for a few days as they have mild to intermediate symptions.
Don't get me wrong, vaccine is what we need, but notice how the timeline is going from 'December' to hopefully we will be vaccinating nursing homes by February.
Just wondering if this means that people with antibodies to SARS CoV - 2 have to go to the back of the line ?![]()
Pfizer tells U.S. officials it cannot supply substantial additional vaccine until late June or July — The Washington Post
Trump administration officials deny there will be availability issues, but others say problems are possible in the second quarter.apple.news